On September 25th, Southern Finance and Economics reported that GlaxoSmithKline (GSK) confirmed to reporters that starting from today (September 25th), Li Weidong will join GSK China as Vice President and Head of Vaccine Business, reporting directly to Yu Huiming, Vice President and General Manager of GSK China. According to public information, Li Weidong was the Vice General Manager and Operations Manager of Wesker Biotech before joining GlaxoSmithKline. (21st Century Business Herald)